ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Complete list of ResMed sponsored studies to be presented at ATS 2024: | | Sunday, May 19, | | --- | --- | | Treatment of sleep-disordered breathing with adaptive servo-ventilation (READ-ASV) in opioid users – a European registry | 2024 | | | 9:15 AM | | | -11:15 AM | | | Sunday | | | May 19, | | 8-year Trends in Obesity, Type 2 Diabetes, and Glucagon-like Peptide-1 (GLP-1) Use in Patients | | | With Obstructive Sleep Apnea | 2024 | | | 9:15 AM - | | | 11:15 AM | ...